Wallington Asset Management Lowers stake in Halyard Health Inc (HYH)

Halyard Health Inc (HYH) : Wallington Asset Management reduced its stake in Halyard Health Inc by 0.08% during the most recent quarter end. The investment management company now holds a total of 8,894 shares of Halyard Health Inc which is valued at $309,244 after selling 7 shares in Halyard Health Inc , the firm said in a disclosure report filed with the SEC on Aug 3, 2016.Halyard Health Inc makes up approximately 0.09% of Wallington Asset Management’s portfolio.

Other Hedge Funds, Including , California Public Employees Retirement System reduced its stake in HYH by selling 3,800 shares or 2.11% in the most recent quarter. The Hedge Fund company now holds 176,045 shares of HYH which is valued at $6,121,085. Halyard Health Inc makes up approx 0.01% of California Public Employees Retirement System’s portfolio.Creative Planning reduced its stake in HYH by selling 242 shares or 4.92% in the most recent quarter. The Hedge Fund company now holds 4,676 shares of HYH which is valued at $161,416. Central Bank Trust Co sold out all of its stake in HYH during the most recent quarter. The investment firm sold 12 shares of HYH which is valued $414.Bnp Paribas Arbitrage Sa boosted its stake in HYH in the latest quarter, The investment management firm added 25,543 additional shares and now holds a total of 28,740 shares of Halyard Health Inc which is valued at $990,668.

Halyard Health Inc closed down -0.29 points or -0.80% at $36 with 3,24,590 shares getting traded on Monday. Post opening the session at $36.26, the shares hit an intraday low of $35.75 and an intraday high of $36.43 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Halyard Health Inc reported $0.45 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Aug 3, 2016. Analyst had a consensus of $0.36. The company had revenue of $400.00 million for the quarter, compared to analysts expectations of $382.39 million. The company’s revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.52 EPS.

Many Wall Street Analysts have commented on Halyard Health Inc. Company shares were Reiterated by Deutsche Bank on Aug 10, 2016 to “Buy”, Firm has raised the Price Target to $ 41 from a previous price target of $36 .Company shares were Reiterated by Stifel on Aug 4, 2016 to “Buy”, Firm has raised the Price Target to $ 38 from a previous price target of $37 .Company shares were Reiterated by Stifel on Jun 14, 2016 to “Buy”, Firm has raised the Price Target to $ 37 from a previous price target of $32 .

Halyard Health Inc. seeks to advance health and healthcare by preventing infection eliminating pain and speeding recovery. The Company has two business segments: Surgical and Infection Prevention (S&IP) and Medical Devices. The Company’s S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. S&IP’s product portfolio includes sterilization wrap surgical drapes and gowns facial protection protective apparel and medical exam gloves. Medical Devices segment provides a portfolio of product offerings including post-operative pain management solutions minimally invasive interventional (or chronic) pain therapies closed airway suction systems and enteral feeding tubes focused on pain management and respiratory and digestive health.

Leave a Reply

Halyard Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Halyard Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.